Clinicopathologic features of gastric cancer infiltrating the lower esophagus

1994 ◽  
Vol 18 (3) ◽  
pp. 428-432 ◽  
Author(s):  
Kimiya Takeshita ◽  
Toshihisa Ashikawa ◽  
Masao Tani ◽  
Naoya Saito ◽  
Michio Maruyama ◽  
...  
1992 ◽  
Vol 6 (2) ◽  
pp. 62-67 ◽  
Author(s):  
K. Takeshita ◽  
H. Habu ◽  
N. Saito ◽  
T. Honda ◽  
M. Iida ◽  
...  

2014 ◽  
Vol 146 (5) ◽  
pp. S-515 ◽  
Author(s):  
Jiong Shi ◽  
Qi Sun ◽  
Huiping Yu ◽  
YiFen Zhang ◽  
Cheng Fang ◽  
...  

2020 ◽  
Author(s):  
Junqing Wang ◽  
Fengjie Hao ◽  
Yuchen Yang ◽  
Xiaochun Fei ◽  
Xunhua Chen

Abstract Background Advanced gastric cancer (GC) induces diamal prognosis and high mortality. Discovery of new biomarkers or differentially expressed genes (DEGs) is serving for early diagnosis, prevention and therapautic treatmen in GC. In this study, by combining with biostatistics analysis, we aimed to verify the aberrant high expression and enhancing effects of SPP1 on GC, and to explore the probable relative post-transcriptional regulation. Methods Three datasets (GSE13911, GSE19826 and GSE27342) from NCBI GEO database were explored. SPP1 was screened out and detected in 105 real GC patients through immunohistochemistry analysis and RT-qPCR assay. The patients’ clinicopathologic features were collected and analyzed. The expression of SPP1 was examinated in three GC cell lines (MKN-45, AGS and SNU-16) . MKN-45 cell model with SPP1 depletd was constrcted through shRNA transfection. CCK8 assay, cell cycle detection and apoptosis rate calculation were conducted to evaluate the ability of cell growth. MiR-4262 was filtered out as a potential up-streaming regulator of SPP1 mRNA through bioinformatic prediction, and the dual-luciferase reporter assay was used for validation. Rescue experiment was introduced to confirm the post-transcriptional regulation. Results Thirteen DEGs increased in GC were selected, among which SPP1 was screened out for its significant over-expression in GC. SPP1 expression profile was validated in both the 105 real GC patients’ samples and three GC cell liens. High SPP1 expression was found significantly associated with the patients’ clinicopathologic features related to unideal prognosis, including tumor size, lymph node metastasis, local invasion grade and TNM stage. Depletion of SPP1 remarkably suppressed the GC cell growth. Whilst, microRNA-4262 was validated directly binding to the 3’-UTR of SPP1 mRNA in GC cells, degenerating the expression of SPP1. Conclusions SPP1 probably functions as an oncogenic gene in GC, and provides us a new biomarker in GC hopeful to promote GC prevention, diagnose and therapeutic treatment.


2013 ◽  
Vol 62 (1) ◽  
pp. 27 ◽  
Author(s):  
Hyun Jung Bok ◽  
Jin Ha Lee ◽  
Jae Kook Shin ◽  
Soung Min Jeon ◽  
Jae Jun Park ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-23
Author(s):  
Xiangchou Yang ◽  
Liping Chen ◽  
Yuting Mao ◽  
Zijing Hu ◽  
Muqing He

The role of an extracellular matrix- (ECM-) receptor interaction signature has not been fully clarified in gastric cancer. This study performed comprehensive analyses on the differentially expressed ECM-related genes, clinicopathologic features, and prognostic application in gastric cancer. The differentially expressed genes between tumorous and matched normal tissues in The Cancer Genome Atlas (TCGA) and validation cohorts were identified by a paired t -test. Consensus clusters were built to find the correlation between clinicopathologic features and subclusters. Then, the least absolute shrinkage and selection operator (lasso) method was used to construct a risk score model. Correlation analyses were made to reveal the relation between risk score-stratified subgroups and clinicopathologic features or significant signatures. In TCGA (26 pairs) and validation cohort (134 pairs), 25 ECM-related genes were significantly highly expressed and 11 genes were downexpressed in gastric cancer. ECM-based subclusters were slightly related to clinicopathologic features. We constructed a risk score model = 0.081 ∗ log 2   CD 36 + 0.043 ∗ log 2   COL 5 A 2 + 0.001 ∗ log 2   ITGB 5 + 0.039 ∗ log 2   SDC 2 + 0.135 ∗ log 2   SV 2 B + 0.012 ∗ log 2   THBS 1 + 0.068 ∗ log 2   VTN + 0.023 ∗ log 2   VWF . The risk score model could well predict the outcome of patients with gastric cancer in both training ( n = 351 , HR: 1.807, 95% CI: 1.292-2.528, P = 0.00046 ) and validation ( n = 300 , HR: 1.866, 95% CI: 1.347-2.584, P = 0.00014 ) cohorts. Besides, risk score-based subgroups were associated with angiogenesis, cell adhesion molecules, complement and coagulation cascades, TGF-beta signaling, and mismatch repair-relevant signatures ( P < 0.0001 ). By univariate (1.845, 95% CI: 1.382-2.462, P < 0.001 ) and multivariate (1.756, 95% CI: 1.284-2.402, P < 0.001 ) analyses, we regarded the risk score as an independent risk factor in gastric cancer. Our findings revealed that ECM compositions became accomplices in the tumorigenesis, progression, and poor survival of gastric cancer.


2020 ◽  
Vol 27 (3) ◽  
pp. 864
Author(s):  
Orhan Uzun ◽  
Aziz Senger ◽  
Mürsit Dincer ◽  
Erdal Polat ◽  
Mustafa Duman ◽  
...  

1997 ◽  
Vol 21 (8) ◽  
pp. 832-836 ◽  
Author(s):  
Kimiya Takeshita ◽  
Masao Tani ◽  
Tooru Honda ◽  
Ichiro Saeki ◽  
Fumio Kando ◽  
...  

2013 ◽  
Vol 24 ◽  
pp. ix15
Author(s):  
J.S. Park ◽  
S. Lim ◽  
H.J. Chon ◽  
M.H. Hong ◽  
B. Kang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document